Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.89B |
| 2 |
Tesla
TSLA
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$1.77B |
| 4 |
VICI Properties
VICI
|
+$1.23B |
| 5 |
Amazon
AMZN
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.57B |
| 2 |
CERN
Cerner Corp
CERN
|
+$3.01B |
| 3 |
Occidental Petroleum
OXY
|
+$1.31B |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.05B |
| 5 |
PBCT
People's United Financial Inc
PBCT
|
+$961M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.63% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
3101
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.11M | ﹤0.01% |
1,674,558
-22,117
| -1% | -$135K |
|
3102
Purple Innovation
PRPL
$41.7M
| $8.1M | ﹤0.01% |
105,906
-8,712
| -8% | -$1.01M |
|
|
NOTV
3103
DELISTED
Inotiv
NOTV
| $8.05M | ﹤0.01% |
839,102
-23,448
| -3% | -$393K |
|
3104
First Watch Restaurant Group
FWRG
$766M
| $8.05M | ﹤0.01% |
558,242
+114,080
| +26% | +$1.55M |
|
|
CMRX
3105
DELISTED
Chimerix, Inc.
CMRX
| $8.04M | ﹤0.01% |
3,866,810
+34,558
| +0.9% | +$111K |
|
|
GTHX
3106
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $8.01M | ﹤0.01% |
1,620,501
-303,203
| -16% | -$1.68M |
|
3107
Timberland Bancorp
TSBK
$351M
| $7.99M | ﹤0.01% |
319,619
-786
| -0.2% | -$20.1K |
|
3108
Meridian
MRBK
$234M
| $7.99M | ﹤0.01% |
527,230
+15,080
| +3% | +$235K |
|
|
KLRS
3109
Kalaris Therapeutics
KLRS
$96.8M
| $7.99M | ﹤0.01% |
89,044
-27,404
| -24% | -$2.87M |
|
3110
Hycroft Mining Holding Corp
HYMC
$2.47B
| $7.99M | ﹤0.01% |
719,580
+568,617
| +377% | +$8.43M |
|
|
STLN
3111
Starling Oncology, Inc. Common Stock
STLN
$641M
| $7.97M | ﹤0.01% |
1,575,435
+737,114
| +88% | +$5.37M |
|
3112
Janux Therapeutics
JANX
$967M
| $7.93M | ﹤0.01% |
649,640
+83,661
| +15% | +$990K |
|
3113
Ceco Environmental
CECO
$4.14B
| $7.93M | ﹤0.01% |
1,326,345
-126,963
| -9% | -$704K |
|
3114
Greene County Bancorp
GCBC
$589M
| $7.93M | ﹤0.01% |
350,134
+61,062
| +21% | +$1.52M |
|
3115
Hooker Furnishings Corp
HOFT
$166M
| $7.91M | ﹤0.01% |
508,530
-50,463
| -9% | -$860K |
|
3116
Evolv Technologies
EVLV
$1.1B
| $7.87M | ﹤0.01% |
2,957,721
+50,216
| +2% | +$134K |
|
3117
Hess Midstream
HESM
$5.11B
| $7.87M | ﹤0.01% |
281,006
+50,158
| +22% | +$1.55M |
|
3118
Nature's Sunshine
NATR
$288M
| $7.87M | ﹤0.01% |
737,068
-85,007
| -10% | -$1.18M |
|
3119
Palladyne AI
PDYN
$296M
| $7.83M | ﹤0.01% |
490,823
+199,276
| +68% | +$4.94M |
|
3120
Aehr Test Systems
AEHR
$3.36B
| $7.82M | ﹤0.01% |
1,042,456
-164,725
| -14% | -$1.37M |
|
|
OMIC
3121
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $7.81M | ﹤0.01% |
68,187
+18,436
| +37% | +$2.16M |
|
|
DLA
3122
DELISTED
Delta Apparel Inc.
DLA
| $7.81M | ﹤0.01% |
275,282
| – | – |
|
3123
Lands' End
LE
$403M
| $7.79M | ﹤0.01% |
733,441
-443,265
| -38% | -$5.82M |
|
3124
Luxfer Holdings
LXFR
$458M
| $7.77M | ﹤0.01% |
513,659
+3,996
| +0.8% | +$64.7K |
|
|
MKFG
3125
DELISTED
Markforged Holding Corporation
MKFG
| $7.77M | ﹤0.01% |
419,818
-3,814
| -0.9% | -$111K |
|
Similar funds
Vanguard Group's Q2 2022 Portfolio in Review
As of Q2 2022, Vanguard Group held 4,705 positions worth $3.56T, down 16% from $4.23T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 3.5%. Vanguard Group opened 80 new positions and exited 84, leaving the 4,705-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q2 2022 buy was ESAB: 5,042,669 shares worth $221M.
- Vanguard Group added most to Warner Bros in Q2 2022, an estimated $2.89B increase.
- Vanguard Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.57B.
- Vanguard Group fully exited Cerner Corp in Q2 2022, selling an estimated $3.01B.
- Vanguard Group's ten largest holdings make up 20% of its $3.56T portfolio in Q2 2022.
- Vanguard Group opened 80 new positions and closed 84 in Q2 2022.
- Vanguard Group's portfolio value fell 16% quarter-over-quarter to $3.56T.
Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.